Telomerase gene screening and telomere overhang detection in Chinese patients with myelodysplastic syndrome

Leukemia Research

Volumn 37, Issue 10, 2013, Pages 1359-1362

  Yan, Siyi ^a   Han, Bing ^a   Li, Hui ^a   Wu, Yongji ^a   Zhou, Daobin ^a   Zhao, Yongqiang ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Myelodysplatic syndrome; Prognosis; Telomerase gene mutation; Telomere overhang

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOGENETICS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GENE; GENE MUTATION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT; TELOMERE HOMEOSTASIS; TERC GENE; TERT GENE;

MYELODYSPLATIC SYNDROME; PROGNOSIS; TELOMERASE GENE MUTATION; TELOMERE OVERHANG;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; TELOMERASE; TELOMERE; YOUNG ADULT;

EID: 84883551320     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2013.06.011     Document Type: Article

References (25)

1. de Lange T., Shiue L., Myers R.M., Cox D.R., Naylor S.L., Killery A.M., et al. Structure and variability of human chromosome ends. Mol Cell Biol 1990, 10(February 2):518-527.
2. Ram R., Uziel O., Lahav M. The importance of the telomere and telomerase system in hematological malignancies. Leuk Lymphoma 2005, 46(August 8):1121-1135.
3. van Steensel B., Smogorzewska A., de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell 1998, 92(February 3):401-413.
4. Griffith J.D., Comeau L., Rosenfield S., Stansel R.M., Bianchi A., Moss H., et al. Mammalian telomeres end in a large duplex loop. Cell 1999, 97(May 4):503-514.
5. Makarov V.L., Hirose Y., Langmore J.P. Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell 1997, 88(March 5):657-666.
6. Calado R.T., Regal J.A., Kajigaya S., Young N.S. Erosion of telomeric single-stranded overhang in patients with aplastic anaemia carrying telomerase complex mutations. Eur J Clin Invest 2009, 39(November 11):1025-1032.
7. Mattarocci S., D'Ambrosio E., Tafaro L., Somma V., Zannino G., Marigliano V., et al. Erosion of telomeric 3' overhangs in white blood cells of aged subjects with high frequency of very short telomeres. Mech Ageing Dev 2011, 132(January-February 1/2):27-32.
8. Brümmendorf T.H., Rufer N., Holyoake T.L., Maciejewski J., Barnett M.J., Eaves C.J., et al. Telomere length dynamics in normal individuals and in patients with hematopoietic stem cell-associated disorders. Ann N Y Acad Sci 2001, 938(June):293-304.
9. Heiss N.S., Knight S.W., Vulliamy T.J., Klauck S.M., Wiemann S., Mason P.J., et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 1998, 19(May 1):32-38.
10. Calado R.T. Telomeres and marrow failure. Hematol Am Soc Hematol Educ Program 2009, 1:338-343. 10.1182/asheducation-2009.1.338.
11. Yamaguchi H. Mutations of telomerase complex genes linked to bone marrow failures. J Nippon Med Sch 2007, 74(June 3):202-209.
12. Kirwan M., Vulliamy T., Marrone A., Walne A.J., Beswick R., Hillmen P., et al. Defining the pathogenic role of telomerase mutations in myelodysplastic syndrome and acute myeloid leukemia. Hum Mutat 2009, 30(November 11):1567-1573.
13. Vardiman J., Hyjek E. World Health Organization classification, evaluation, and genetics of the myeloproliferative neoplasm variants. Hematol Am Soc Hematol Educ Program 2011, 1:250-256. 10.1182/asheducation-2011.1.250.
14. Han B., Liu B., Cui W., Wang X., Lin J., Zhao Y. Telomerase gene mutation screening in Chinese patients with aplastic anemia. Leuk Res 2010, 34(February 2):258-260.
15. Cimino-Reale G., Pascale E., Battiloro E., Starace G., Verna R., D'Ambrosio E. The length of telomeric G-rich strand 3'-overhang measured by oligonucleotide ligation assay. Nucleic Acids Res 2001, 29(April 7):E35.
16. Gancarcíková M., Zemanová Z., Brezinová J., Berková A., Vcelíková S., Smigová J., et al. The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease. Prague Med Rep 2010, 111(2):91-105.
17. Yamaguchi H., Baerlocher G.M., Lansdorp P.M., Chanock S.J., Nunez O., Sloand E., et al. Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood 2003, 102(August 3):916-918.
18. Field J.J., Mason P.J., An P., Kasai Y., McLellan M., Jaeger S., et al. Low frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome. J Pediatr Hematol Oncol 2006, 28(July 7):450-453.
19. Lange K., Holm L., Vang Nielsen K., Hahn A., Hofmann W., Kreipe H., et al. Telomere shortening and chromosomal instability in myelodysplastic syndromes. Genes Chromosomes Cancer 2010, 49(March 3):260-269.
20. Holme H., Hossain U., Kirwan M., Walne A., Vulliamy T., Dokal I. Marked genetic heterogeneity in familial myelodysplasia/acute myeloid leukaemia. Br J Haematol 2012, 158(July 2):242-248.
21. Rollison D.E., Epling-Burnette P.K., Park J.Y., Lee J.H., Park H., Jonathan K., et al. Telomere length in myelodysplastic syndromes. Leuk Lymphoma 2011, 52(August 8):1528-1536.
22. Rigolin G.M., Porta M.D., Bugli A.M., Castagnari B., Mauro E., Bragotti L.Z., et al. Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: correlations with aetiological and clinical-biological findings. Eur J Haematol 2004, 73(November 5):351-358.
23. Gürkan E., Tanriverdi K., Başlamişli F. Telomerase activity in myelodysplastic syndromes. Leuk Res 2005, 29(October 10):1131-1139.
24. Mittelman M., Oster H.S., Hoffman M., Neumann D. The lower risk MDS patient at risk of rapid progression. Leuk Res 2010, 34(December 12):1551-1555.
25. Scheinberg P., Cooper J.N., Sloand E.M., Wu C.O., Calado R.T., Young N.S. Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia. JAMA 2010, 304(September 12):1358-1364.